Cofactor Genomics is bridging the precision medicine gap by building diagnostic tools to match the right patient to the right treatment at the right time. Predicting patient response currently relies on isolated, single-analyte biomarkers that have failed to deliver accurate therapy response predictions, resulting in unnecessary healthcare costs, and most harmfully, negative outcomes for patients. Cofactor’s products use Predictive Immune Modeling, which leverages RNA data and machine learning to combine biological signals, creating multidimensional biomarkers to deliver on the promise of precision medicine. Cofactor Genomics offers its full-service molecular, informatic, and database tools to make drug discovery, clinical trials and therapy selection more successful. Find out more about how Cofactor Genomics is revolutionizing precision medicine at cofactorgenomics.com.
Looking for a particular Cofactor Genomics employee's phone or email?
The Cofactor Genomics annual revenue was $6 million in 2026.
Cofactor Genomics is based in St. Louis, Missouri.
The NAICS codes for Cofactor Genomics are [541, 54171, 54, 5417, 541714].
The SIC codes for Cofactor Genomics are [873, 87].